Tango Therapeutics Inc [TNGX] stock prices are down -9.28% to $10.66 at the moment. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The TNGX shares have gain 19.64% over the last week, with a monthly amount glided 16.25%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Previously, Piper Sandler started tracking the stock with Overweight rating on August 19, 2025, and set its price target to $11. On July 17, 2024, Jefferies initiated with a Buy rating and assigned a price target of $19 on the stock. Cantor Fitzgerald started tracking the stock assigning an Overweight rating. Piper Sandler initiated its recommendation with an Overweight and recommended $18 as its price target on February 12, 2024. B. Riley Securities started tracking with a Buy rating for this stock on December 08, 2023, and assigned it a price target of $16. In a note dated October 20, 2022, H.C. Wainwright upgraded a Buy rating on this stock but restated the target price of $10.
The stock price of Tango Therapeutics Inc [TNGX] has been fluctuating between $1.03 and $12.11 over the past year. Currently, Wall Street analysts expect the stock to reach $13.5 within the next 12 months. Tango Therapeutics Inc [NASDAQ: TNGX] shares were valued at $10.66 at the most recent close of the market. An investor can expect a potential return of 26.64% based on the average TNGX price forecast.
Analyzing the TNGX fundamentals
The Tango Therapeutics Inc [NASDAQ:TNGX] reported sales of 66.50M for trailing twelve months, representing a surge of 363.61%. Gross Profit Margin for this corporation currently stands at 0.98% with Operating Profit Margin at -1.66%, Pretax Profit Margin comes in at -1.51%, and Net Profit Margin reading is -1.51%. To continue investigating profitability, this company’s Return on Assets is posted at -0.48, Equity is -0.61 and Total Capital is -0.58. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.22.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance.
Ratios To Look Out For
It’s worth pointing out that Tango Therapeutics Inc [NASDAQ:TNGX]’s Current Ratio is 8.88. Also, the Quick Ratio is 8.88, while the Cash Ratio stands at 3.16. Considering the valuation of this stock, the price to sales ratio is 21.59, the price to book ratio is 7.43.
Transactions by insiders
Recent insider trading involved Third Rock Ventures IV, L.P., 10% Owner, that happened on Oct 23 ’25 when 0.48 million shares were sold. 10% Owner, Third Rock Ventures IV, L.P. completed a deal on Oct 23 ’25 to buy 0.48 million shares. Meanwhile, 10% Owner Third Rock Ventures IV, L.P. sold 0.5 million shares on Sep 25 ’25.
